Sleep Apnea Devices Market Size, Share and Global Trend By Device Type (Diagnostic Devices, Therapeutic Devices), By End User (Hospitals & Clinics, Sleep Laboratories, Homecare Settings, Others), and Geography Forecast till 2026

Sleep apnea referred to as a sleep disorder, which can be potentially serious, wherein the breathing of the individual repeatedly stops or interrupted and then starts again. Sleep apnea can be classified into three types: central sleep apnea, complex sleep apnea syndrome, and obstructive sleep apnea. Obstructive sleep apnea is the most common form. In many instances of sleep apnea, the symptoms of obstructive and central sleep apnea overlap with each other, making it hard to distinguish the type of sleep apnea.

Some of the common symptoms of both the disorders include episodes of individual stops breathing while sleeping, loud snoring, gasping for breath during sleep, headaches in the morning, insomnia at night and excessive drowsiness during the day. Some of the factors contributing to individuals at risk of being diagnosed with sleep apnea include obesity, aging, male, familial history, narrow neck circumference, nasal congestion, smoking and usage of alcohol & sedatives. Sleep apnea devices such as continuous positive airway pressure (CPAP) help in the alleviation of the symptoms of sleep apnea, but if left completely untreated it may lead to complications such as fatigue, type 2 diabetes, hypertension, and metabolic syndrome. The increasing prevalence of sleep apnea among individuals is one of the key reasons for the positive growth of the sleep apnea devices market.

To get information on various segments, share your queries with us

The global sleep apnea devices market is anticipated to grow, owing to several factors such as the increased prevalence of sleep apnea, increase in the prevalence of lifestyle disorders such as obesity, and rising geriatric population. Moreover, increased government initiatives, demand for advanced medical technologies, increased funding for research & development activities, greater demand for homecare treatment solutions, and increasing awareness regarding sleep apnea are some other factors expected to drive the market growth. The National Sleep Foundation estimated that more than 18 million Americans have sleep apnea across all ages and sexes, with the childhood prevalence of sleep apnea estimated to be at least 2-3%, which may go higher up to 20-30% in habitually snoring children. These trends, combined with the other factors, are expected to drive the market growth positively.

The factors limiting the growth of the global sleep apnea devices market includes the expensiveness of the devices, the availability of alternatives, and stringent regulations for the production of devices.

Key Players Covered

Some of the major companies that are present in the global sleep apnea devices market are GENERAL ELECTRIC, Cadwell Industries, Inc., Oventus, Koninklijke Philips N.V., Löwenstein Medical GmbH & Co. KG., ResMed, Braebon Medical Corporation, Fisher & Paykel Healthcare Limited., SomnoMed and Compumedics Limited, and others.

SEGMENTATION

Among the segmentation, Polysomnography Devices (PSG) in the diagnostic devices segment is projected to hold a considerable share of the global sleep apnea devices market because these devices are considered as the gold standard for the diagnosis of sleep-associated breathing disorders such as sleep apnea.

Key Insights

• Number of sleep apnea clinics by key countries
• Number of incidences of sleep apnea by key countries
• Recent industry developments such as partnerships, mergers, and acquisitions
• Overview of technological advancements
• Overview of cost of care of sleep apnea
• New product launches

Regional Analysis

North America accounts for the largest share in the global sleep apnea devices market due to the increasing prevalence of sleep apnea, increasing incidences of obesity, developed healthcare system, high healthcare expenditures, access to and high rates of adoption of advanced medical technologies and awareness of the introduction of new devices in the market. The Asia Pacific is the fastest emerging market due to the large population pools, aging population, increasing awareness of the disorders, increasing incidences of sleep apnea, increasing individuals with obesity, adoption of advanced medical technologies and rising disposable incomes.

Key Industry Developments

• In January 2019, Oventus launched the lightweight sleep apnea treatment device called the Optima device, which is a 3D-printed nylon oral appliance that allows the jaw forward to open the airway, in Australia
• In October 2018, Beddr (Hancock Medical, Inc.) launched the Sleep Tuner, a sensor worn on the forehead for the sleep apnea patients
•  In October 2017, the Food and Drug Administration (FDA) approved an implantable device for the treatment of moderate to severe central sleep apnea, called the Remedē System